Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CrossAmerica Partners LP Unit | CAPL | Nov 22, 2024 | 20.32 | +0.49 |
CrossFirst Bankshares | CFB | Nov 22, 2024 | 17.96 | +2.57 |
CrowdStrike A | CRWD | Nov 22, 2024 | 372.26 | +4.11 |
Crown Castle | CCI | Nov 22, 2024 | 105.44 | +0.90 |
Crown Crafts | CRWS | Nov 22, 2024 | 4.52 | +0.44 |
Crown ElectroKinetics | CRKN | Nov 22, 2024 | 0.66 | -17.59 |
Crown Holdings | CCK | Nov 22, 2024 | 92.82 | +1.99 |
Crown LNG | CGBS | Nov 22, 2024 | 0.34 | +4.58 |
Cryo-Cell International | CCEL | Nov 22, 2024 | 8.35 | +0.60 |
CryoPort | CYRX | Nov 22, 2024 | 6.56 | +0.61 |
CS Disco | LAW | Nov 22, 2024 | 5.79 | +4.32 |
CSG Systems International | CSGS | Nov 22, 2024 | 55.51 | +0.56 |
CSP | CSPI | Nov 22, 2024 | 17.18 | +21.07 |
CSW Industrials | CSWI | Nov 22, 2024 | 426.66 | +2.65 |
CSX | CSX | Nov 22, 2024 | 35.78 | +1.25 |
CTO Realty Growth | CTO | Nov 22, 2024 | 19.81 | +0.76 |
CTO Realty Growth A Pref | CTO-A | Nov 22, 2024 | 23.70 | +0.72 |
CTS | CTS | Nov 22, 2024 | 54.29 | +2.09 |
CubeSmart | CUBE | Nov 22, 2024 | 48.91 | +0.64 |
Cue Biopharma | CUE | Nov 22, 2024 | 1.02 | -0.97 |
Cullen Frost Bankers B Pref | CFR-B | Nov 22, 2024 | 19.52 | -0.12 |
Cullen/Frost Bankers | CFR | Nov 22, 2024 | 142.32 | +2.00 |
Cullinan Therapeutics | CGEM | Nov 22, 2024 | 12.54 | +2.62 |
Cullman Bancorp | CULL | Nov 22, 2024 | 9.71 | 0.00 |
Culp | CULP | Nov 22, 2024 | 5.16 | +1.38 |
Cumberland Pharmaceuticals | CPIX | Nov 22, 2024 | 1.06 | -1.85 |
Cummins | CMI | Nov 22, 2024 | 372.62 | +1.02 |
Cumulus Media A | CMLS | Nov 22, 2024 | 0.73 | -1.22 |
Curbline Properties | CURB | Nov 22, 2024 | 23.68 | 0.00 |
Curevac N.V. | CVAC | Nov 22, 2024 | 2.66 | +3.91 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.